My long COVID challenges

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Our reviewer takes the Mitopure Challenge to see if he is a urolithin A super-producer – or whether he should consider supplementation.

A year ago today, my energy levels were through the roof. Working three jobs, hard workouts every day, coming home in the evening to play with my two-year-old son – bring it on! I would go to bed at 11 pm with some energy left to spare.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

LTUI: 2032

Amazentis

Longevity level(s):

  • Level 3: Longevity biohacking
    Companies that manufacture ingredients and dietary supplements, or produce equipment such as red light therapy, cryonic chambers, and enhanced exercise equipment to maintain the metabolism and replace cellular function lost with the progression of age.
  • Level 6: Aging disease prevention therapeutics
    Therapeutic interventions that control aging drivers to prevent aging diseases from occurring, like the current wave of GLP-1 agonists that prevent type 2 diabetes through metabolic interventions that also are proving effective in mitigating cardiovascular and neurological diseases.

Overview

Amazentis is a biotech company headquartered in Lausanne, Switzerland, operating at the intersection of nutrition and pharmaceutical science to develop therapeutically validated products targeting cellular aging. The company's flagship asset, Mitopure (Urolithin A), is a proprietary postbiotic compound clinically demonstrated to activate mitophagy—the cellular recycling process—thereby improving mitochondrial function, muscle strength, and endurance in aging populations. Through its consumer health brand Timeline, Amazentis delivers science-backed nutritional interventions designed to extend healthspan by addressing fundamental hallmarks of aging, particularly mitochondrial dysfunction and cellular senescence.

Access all data points on DLT:

  • Financial Data
  • Patents
  • Technology
  • Management
  • Advisory Board
  • News
  • Classifications
  • Similar Companies
Expand

Girish Harinath

Scientific Editor

Girish is a cell biologist/neuroscientist with a Master of Business and Science degree in Biotechnology and Genomics and nearly 13 years of experience within academia studying the molecular underpinnings of healthy aging and chronic disease. Girish has consulted as a scientific researcher, writer and advisor for several companies within the longevity ecosystem and is extremely passionate about merging his scientific knowledge with his entrepreneurial skillsets to empower individuals to take control of their aging journey.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE